Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer
- 1 September 2005
- journal article
- clinical trial
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 19 (6) , 491-497
- https://doi.org/10.1007/bf02985577
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical Applications of PET in OncologyRadiology, 2004
- Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”—Annals of Nuclear Medicine, 2003
- Clinical Value of Positron Emission Tomography with FDG for Recurrent Ovarian CancerAmerican Journal of Roentgenology, 2001
- Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT.American Journal of Roentgenology, 1999
- Diagnosis of pancreatic carcinoma: role of FDG PET.American Journal of Roentgenology, 1998
- Cancer screening with whole-body F-fluorodeoxyglucose positron-emission tomographyThe Lancet, 1997
- Pancreatic carcinomaThe Lancet, 1997
- Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures.Radiology, 1996
- Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancerBritish Journal of Surgery, 1995
- Carcinoma of the Pancreatic Head and Periampullary Region Tumor Staging with Laparoscopy and Laparoscopic UltrasonographyAnnals of Surgery, 1995